Pharmaceutical giant GlaxoSmithKline has just strengthened its vaccine business with the acquisition of Okairos AG, a developer of vaccine platform technologies, for 250 million .
http://www.medilexicon.com/medicalnews.php?newsid=261178
http://www.medilexicon.com/medicalnews.php?newsid=261178
No comments:
Post a Comment